SOAS Training Program | SUMOylation as a Target to Activate Anti-tumor Immune Response to Treat PDAC

Thursday, November 16, 3:00pm - 4:00pm (EST)

Time shown in-04:00 America, New York

Yuan Chen, Ph.D., joined the UC San Diego Department of Surgery in January 2020 as a Professor in the Division of Surgical Oncology focusing on research. Dr. Chen obtained a Ph.D. in Biochemistry from Rutgers University and completed post-doctoral studies at the Scripps Research Institute. In 1994 she joined City of Hope as a faculty and was promoted to full Professor in 2005. She served on various leadership roles including the Dean of Transdisciplinary Research at the Beckman Research Institute of the City of Hope. Dr. Chen’s current research interests center on the role of ubiquitin-like modifications in anti-tumor immune response and the development of therapies to target novel mechanisms to treat recalcitrant cancers like pancreatic cancer. Dr. Chen’s research has been funded by the NIH, the California Institute of Regenerative Medicine, and the Pancreatic Cancer Action Network. Learn more about her research

Please fill out the information below to register for the event.

Going
Interested
Can't go

Name

Attending

You're going to "SOAS Training Program | SUMOylation as a Target to Activate Anti-tumor Immune Response to Treat PDAC".

We've sent a confirmation email to your email address. Be sure to check your junk folder in case you haven't received the confirmation.

Add to Calendar 2023/11/16 12:00:00 2023/11/16 13:00:00 America/Los_Angeles SOAS Training Program | SUMOylation as a Target to Activate Anti-tumor Immune Response to Treat PDAC Yuan Chen, Ph.D., joined the UC San Diego Department of Surgery in January 2020 as a Professor in the Division of Surgical Oncology focusing on research. Dr. Chen obtained a Ph.D. in Biochemistry from Rutgers University and completed post-doctoral studies at the Scripps Research Institute. In 1994 she joined City of Hope as a faculty and was promoted to full Professor in 2005. She served on various leadership roles including the Dean of Transdisciplinary Research at the Beckman Research Institute of the City of Hope. Dr. Chen’s current research interests center on the role of ubiquitin-like modifications in anti-tumor immune response and the development of therapies to target novel mechanisms to treat recalcitrant cancers like pancreatic cancer. Dr. Chen’s research has been funded by the NIH, the California Institute of Regenerative Medicine, and the Pancreatic Cancer Action Network. Learn more about her research Comer Commons, Moores Cancer Center false MM/DD/YYYY 60 OPAQUE aRHTJAtebzuytgVCsmlE218689

You're interested in "SOAS Training Program | SUMOylation as a Target to Activate Anti-tumor Immune Response to Treat PDAC".

We've sent a confirmation email to your email address. Be sure to check your junk folder in case you haven't received the confirmation.

Thank you!

Your changes have been saved. Thanks for keeping us updated.

Comer Commons, Moores Cancer Center

Yuan Chen, PhD

Link: